leisure time -WSS

leisure time

author：knowledge 2025-09-29 00:34:03 - browse：28394

Matts Take Column Illustration — Molly Ferguson for STAT

American medicine is a tragic paradox. An example: Cancer patients are likely dying as a result of drug shortages that occurred partly because generic chemotherapies have been allowed to become too cheap. At the same time, other patients are suffering, and perhaps dying, because the financial burden brought on by the expensive medicines they need is too high.

Sit with that like a terrible Zen koan: Medicines are both too cheap and too expensive.

How is that possible? A lot of it goes back to the 1984 Hatch-Waxman Act, which set up the ecosystem that determines the process by which drugs go from being expensive brands to cheap generics in the U.S.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The cancer drug shortage isn’t new — and neither are the solutions
Next article： Average age of first period drops to 11.9 years, study shows

focus

WSS

Lab trade group sues FDA to halt regulation of lab

AI models in health care face new federal disclosure requirements

Congenital heart disease patients face new threat of heart failure

Spinal cord stimulation reduces pain in amputees, study finds

Spinal cord stimulation reduces pain in amputees, study finds

Americans' trust in science, scientist continues decline: Report

Wikipedia

leisure time

hotspot

Activists slam private health insurers over coverage restrictions

Lab trade group sues FDA to halt regulation of lab

Bright Health sells Medicare Advantage business to Molina

Do more moles mean more problems? Not so, says new study

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Radiology is caught between AI's potential and concern for patients

Medical leaders decry Supreme Court decision on affirmative action

David Sabatini, ex

Malaria cases in Florida and Texas: Here’s what you need to know

Roche to buy Carmot Therapeutics, developer of obesity drugs

hotspot

David Sabatini, ex

Spinal cord stimulation reduces pain in amputees, study finds

Spinal cord stimulation reduces pain in amputees, study finds

Supreme Court wrestles with OxyContin maker's bankruptcy deal

Readout Newsletter: Insmed, Asahi Kasei, Agios, Royalty Pharma

Pharma patents targeted by Biden in move to slash drug prices

explore

focus

focus

hotspot